Market revenue in 2023 | USD 3,813.2 million |
Market revenue in 2030 | USD 5,590.2 million |
Growth rate | 5.6% (CAGR from 2023 to 2030) |
Largest segment | Peripheral stents |
Fastest growing segment | Hemodynamic Flow Alteration Devices |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | PTA Balloons, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Peripheral Accessories, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices, Peripheral Stents |
Key market players worldwide | Abbott Laboratories, Edwards Lifesciences Corp, Medtronic PLC, St. Jude Medical, Teleflex Inc, Philips, Boston Scientific Corp, Cook Group, Covidien, AngioScore |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to peripheral vascular devices market will help companies and investors design strategic landscapes.
Peripheral stents was the largest segment with a revenue share of 22.86% in 2024. Horizon Databook has segmented the North America peripheral vascular devices market based on pta balloons, catheters, endovascular aneurysm repair stent grafts, plaque modification devices, peripheral accessories, inferior vena cava filters, hemodynamic flow alteration devices, peripheral stents covering the revenue growth of each sub-segment from 2018 to 2030.
North America dominated the global peripheral vascular devices market in 2023. The peripheral vascular devices market exhibits consistent growth owing to several factors including the growing incidence of Peripheral Artery Disease (PAD), rising geriatric population, and rapid advancements in medical technology.
For instance, the article published by the American Heart Association (AHA) journal in June 2023 stated that the prevalence of PAD impacts an estimated 7 to 12 million individuals in the U.S. Globally, this vascular condition affects a substantial demographic, with approximately 200 million people being affected with PAD globally.
The growing prevalence of PAD necessitates medical intervention and therapeutic measures. This surge highlights the increased demand for cutting-edge peripheral vascular devices crucial in both diagnosing and managing PAD.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America peripheral vascular devices market, including forecasts for subscribers. This continent databook contains high-level insights into North America peripheral vascular devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account